First Trust NYSE Arca Biotechnology Index Fund (FBT)
| 158.91 Delayed Data As of Nov 29 |  +0.17 / +0.11%Today’s Change | 154.29 Today|||52-Week Range 186.51 | -5.41% Year-to-Date |
Investment Objective
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Latest FBT News
No recent news for First Trust NYSE Arca Biotechnology Index Fund.
Performance
| 1 month | -4.15% | 3 years | +5.00% | |
| 3 months | -8.00% | 5 years | +9.76% | |
| 1 year | -0.47% | Since inception | +14.45% |
Data through 11/27/2021
Quote Details
| Previous close | $158.74 |
| Open day’s range | 158.91 – 161.30 |
| Net asset value (NAV) | 158.47 (11/26/2021) |
| Daily volume | 37,093 |
| Average volume (3 months) | 38,569 |
Data as of 3:59pm ET, 11/29/2021
Peer Comparisonvs. Health ETFs
| FBT | Category | |
|---|---|---|
| Performance 5-yr return | +9.76% | +13.75% |
| Expense Gross exp ratio | 0.55% | 1.00% |
| Risk 5 year sharpe ratio | 0.65 | 0.91 |
| Net assets | $1.8B | $2.4B |
| Average market cap | $15.0B | $37.7B |
| Average P/E | 25.5 | 25.0 |
| Dividend / Share | -- | 0.29% |
Competitors
| RYH Invesco S&P 500® Equal Weight Health Ca... |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 100.00% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| REGN Regeneron Pharmaceuticals | 3.82% |
| BNTX BioNTech SE | 3.72% |
| BLUE bluebird bio Inc | 3.70% |
| CRL Charles River Laboratories International Inc | 3.67% |
| -- | 3.57% |
| MRNA Moderna Inc | 3.52% |
| TECH Bio-Techne Corp | 3.48% |
| IQV IQVIA Holdings Inc | 3.47% |
| RARE Ultragenyx Pharmaceutical Inc | 3.47% |
| BMRN Biomarin Pharmaceutical Inc | 3.45% |
